Why Valeant, Fitbit & Three Other Stocks Are Deep in Red Today
On Wednesday, major U.S. stock indexes are posting gains of more than 0.50%.
Posts Tagged ‘Valeant Pharmaceuticals Intl Inc (VRX)’
Starboard Sets Out to Remove Yahoo! Inc. (YHOO)’s Entire Board, ValueAct Further Trims Adobe Stake, Plus 2 Other Moves
According to fresh data from Hedge Fund Research, the activist hedge fund industry lost 6.52% in the first two months of this year, versus the decline of 2% for the average hedge...
Office Depot (ODP), Valeant (VRX) Among 5 of the Day’s Big Winners
It's a red day for the markets, with all major U.S. indexes down, along with crude oil and gold. However, a few stocks are registering important gains in the early afternoon.
Why Valeant, Alibaba, Valspar, Starwood & MannKind Are All Up Today
The stock market is up slightly on Monday, with major U.S stock indexes posting gains of between 0.1% and 0.2%.
Hedge Funds Are Hoarding Shares of These 5 Large-Caps
Outperforming the market with large-cap stocks is not an easy task.
Are Hedge Funds Losing Interest in Valeant Pharmaceuticals Intl Inc (VRX)?
The majority of people around the globe does not known what a stock means, how equity markets work and what their benefits are. Unfortunately, this is a true fact.
Billionaire Jeffrey Ubben’s Latest Moves and His Top Bets This Year
Billionaire Jeffrey Ubben is among the few activist investors today who, unlike more aggressive activists that pressurize companies to accept their demands, focuses on establishing...
Why Are These Five Stocks Tumbling on Tuesday?
The market spiked Tuesday, with all major U.S. indexes trading up by more than 1.5%.
Five Healthcare Stocks Hedge Funds Are Bullish On
Since the beginning of 2016, the healthcare sector has been one of the worst performing and is down by almost 8.80% year-to-date, outperforming only the financial sector that ...
Nehal Chopra’s Top Moves Going Into 2016
Diversification has been a buzzword in the investment industry for a long time.
These Were Billionaire John Paulson’s Biggest Moves in Q4
In the last few years, we have seen billionaire John Paulson transform from a money manager who bets big on activist and merger deals to an activist investor himself.
An In-Depth Look at Billionaire Bill Ackman’s Concentrated Equity Portfolio
Renowned activist investor Bill Ackman has been removed from the list of 20 best-performing hedge fund managers in history, after his fund Pershing Square Capital Management ...
Five Foreign Stocks Hedge Funds Love
The easiest way to reduce a portfolio's exposure to local factors, which could both be macroeconomic or industry specific, is to invest in foreign companies listed on local exchanges...
Billionaire Bill Ackman Buys More Valeant Shares, Starboard Value Gradually Jettisons Darden Restaurants Inc. (DRI) Stake and Two Other Moves
Hedge fund vehicles had a rough 2015, and the beginning of 2016 does not look too great either.
Here’s How Billionaire Bill Ackman’s Top Picks Performed In the Fourth Quarter
Known for his activism and long term views, Bill Ackman's Pershing Square is one of the best hedge funds in the world.
Top 20 Most Popular Stocks Among Financial Advisors Dominated by Tech and Healthcare
With investors preparing to enter 2016, several interesting trends could have been noticed in the last trading week of December.
Here’s Why These Five Stocks Are Trending on Wednesday
With the three major indexes down 1% or more, T-Mobile US Inc (NASDAQ:TMUS), Sirius XM Holdings Inc.
Why Are These Stocks In The Red Amid Today’s Rally?
It looks like U.S. stocks are set to end 2015 on a positive note, with most sectors rallying today, pushed by a solid advance in oil prices.
What Sent These Five Stocks Lower on Monday?
The US stock market started the last trading week of 2015 on a slightly negative note, with major indices losing ground on Monday.
Billionaire Jeff Ubben’s Top Five Long-Term Picks
Jeff Ubben of ValueAct Capital is a pretty successful investor. Not only has he built up his fund to have an equity portfolio of $17.20 billion since founding ValueAct in 2000...
Here Is Why Investors Are Talking Technology and Biotech This Morning
The highly anticipated interest rate hike took place on Wednesday, as the Fed lifted rates by 25 basis points, for the first time since 2006.
Why Are These Stocks Trending Today?
It's Wednesday and the S&P 500 futures are still firmly in the green in pre-market trading despite the fact that the Federal Reserve is set to raise rates in its FOMC meeting ...
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate...
Hedge Funds Were Right to Ditch These Sinking Stocks, Part 2
We at Insider Monkey like to follow the smart money's collective sentiment, as our research has shown that we can improve our chances of outperforming the market by doing so.
The Smart Money is Hoarding Shares of These 10 Healthcare Stocks, Part 2
In the first part in our series, we covered five healthcare stocks that the hedge funds in our database have favored heavily for one reason or another, owning a high concentration...
Visium Asset Management Is a Staunch Supporter of These 5 Healthcare Stocks
Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September 30.
Billionaire Investors Are Betting on These Healthcare Stocks in Q4
The third quarter of 2015 was one of the worst periods that stocks from the healthcare sector have seen in the recent times.
Billionaire Bill Ackman Puts His Money Where His Mouth Is, While Carl Icahn Reveals His Newest Activist Target
The stock selection process is generally quite cumbersome and expensive on some occasions, especially when one does not have the necessary knowledge base and skills to pursue ...
Jeffrey Ubben’s Top 5 Q4 Stock Picks
ValueAct Capital, led by Jeffrey Ubben, recently submitted its latest 13F to the Securities and Exchange Commission for the reporting period of September 30.
Four Stocks That Have Investors Buzzing Today
U.S stocks are trading in a narrow range this morning, as investors are digesting corporate news and looking for further clues as to a potential rate hike in December.
Billionaire Stephen Mandel Remains Among Valeant Bulls; Betting Big on Tech in Q4
Billionaire Stephen Mandel's Lone Pine Capital lost money in the third quarter, although three of its funds: Lone Cypress, Lone Kauri, and Lone Tamarack declined by 3.5%, 3.6...
Billionaire Leon Cooperman’s Big Moves On Valeant, Facebook, GM, More
Billionaire Leon Cooperman of Omega Advisors is one of the most influential investors in the world, and also one of the wealthiest, with Forbes currently ranking him as the 514th...
Here’s How Billionaire John Paulson Traded Valeant and His Other Top Stock Picks Last Quarter
Hedge fund manager John Paulson, who founded Paulson & Co. back in 1994, has become very popular since he made a fortune betting against subprime mortgages in 2007.
A Look at Bill Ackman’s Top Bets for Q4
As an activist, Bill Ackman prefers to hold a concentrated equity portfolio that allows him to focus on his targets and work towards maximizing their shareholder value.
Why Are These Five Stocks on the Move Today?
With the broader market down by more than half a percent, shares of International Game Technology Ordinary Shares (NYSE:IGT), Freshpet Inc (NASDAQ:FRPT), Advance Auto Parts, ...
Healthcare-Focused Investor Sees Valeant’s Value at $50; Smart Money Mixed on Stock
As a volatile, but rather profitable sector, healthcare is the focus of many investors.
These Four Stocks Are Leading Today’s Losers Pack for Various Reasons
Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red. Valeant Pharmaceuticals Intl Inc (NYSE:VRX), ...
Billion Dollar Hedge Fund Iridian Asset Management Loves These Five Stocks. Should You?
David Cohen and Harold Levy, a duo of special situation investors with a focus on depressed stocks that go through significant changes, founded Iridian Asset Management in 1996...
Impressions From Billionaire Carl Icahn’s Discussion At The DealBook Conference
Billionaire Carl Icahn is one of the most feared activist investors on Wall Street and Insider Monkey had the pleasure to hear him speak at the DealBook conference at the Whitney...
Here’s Why These Four Stocks Are Trending Today
It's the start of another week of what should amount to compelling trading activity and shares of Amazon.com, Inc.
A Look at Larry Robbins’ Take on the Pharma Industry and Four Picks He Is Bullish On
Larry Robbins of Glenview Capital is one of the most widely-watched investors on Wall Street.
What You Need To Know About These 4 Hot Stocks
Shares of Lendingtree Inc (NASDAQ:TREE), Grupo Financiero Galicia S.A.
These Stocks Are in Spotlight on Monday for Various Reasons
Markets are heading into a new week with several important events, including earnings releases of several major players and a two-day Fed meeting, following which investors will...
Here’s Why These Four Stocks Fell Like Rocks Today
Shares of Endo International plc - Ordinary Shares (NASDAQ:ENDP), Horizon Pharma PLC (NASDAQ:HZNP), Werner Enterprises, Inc.
What You Need To Know About These 4 Sinking Stocks
The markets are up this morning thanks to positivity surrounding the strong earnings results of McDonald’s Corporation (NYSE:MCD), among other companies.
What Sparked the Large Moves of These Five Stocks?
It's Wednesday, and shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Concordia Healthcare Corp (NASDAQ:CXRX), SanDisk Corporation (NASDAQ:SNDK), NeoGenomics, Inc.
Valeant, Morgan Stanley, Genocea: Stocks In The Spotlight For The Wrong Reasons Today
It's Monday and shareholders of Morgan Stanley (NYSE:MS), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Genocea Biosciences Inc (NASDAQ:GNCA) are certainly on alert as the...
This Activist Investor’s Picks May Be Lagging But They Are Poised For Long-Term Growth
Jeff Ubben of ValueAct Capital is one of the 40 or so billionaire investors that we follow at Insider Monkey.
How Did Stephen Mandel’s Portfolio Come Through the Third Quarter?
The returns of the U.S.
